Abstract
Background: CVDs are the first cause of death globally. About 50% of annual deaths are
related to this group of diseases in Iran; however, the economic cost of CVD on Iranian
society has not been conducted.
Objectives: The aim of this study was to estimate the economic burden of CVDs in the
southwest of Iran in 2016 from the social perspective.
Materials and Methods: This study is a cross-sectional descriptive-analytic study
conducted using the cost of illness (COI) framework. The prevalence top-down method
was used to quantify the annual cardiovascular costs. Productivity losses were estimated
using the human capital approach and the friction cost method, with the discount rate
of 3% to convert all future lifetime earnings into the present value.
Results: In 2016, the average total cost per patient was $1881.4 and the total costs resulted
in 1159.62 $million. Direct costs accounted for 60% and indirect costs for 40% of the total
costs. The results were robust to a 20% change in the average unit price of all medical and
non- medical direct costs and to discount rate of 2% and 10%.
Conclusions: The total cardiovascular disease costs in 2016 represented approximately
6.7% of the Iran gross domestic product. The results of this study would be of special help
for policymakers to evaluate the cost-effectiveness and outcomes of health care programs
to allocate health care resources efficiently. Primordial Prevention of CVD including
lifestyle modifications and dietary interventions resulted in substantial financial savings
and is strongly recommended.
related to this group of diseases in Iran; however, the economic cost of CVD on Iranian
society has not been conducted.
Objectives: The aim of this study was to estimate the economic burden of CVDs in the
southwest of Iran in 2016 from the social perspective.
Materials and Methods: This study is a cross-sectional descriptive-analytic study
conducted using the cost of illness (COI) framework. The prevalence top-down method
was used to quantify the annual cardiovascular costs. Productivity losses were estimated
using the human capital approach and the friction cost method, with the discount rate
of 3% to convert all future lifetime earnings into the present value.
Results: In 2016, the average total cost per patient was $1881.4 and the total costs resulted
in 1159.62 $million. Direct costs accounted for 60% and indirect costs for 40% of the total
costs. The results were robust to a 20% change in the average unit price of all medical and
non- medical direct costs and to discount rate of 2% and 10%.
Conclusions: The total cardiovascular disease costs in 2016 represented approximately
6.7% of the Iran gross domestic product. The results of this study would be of special help
for policymakers to evaluate the cost-effectiveness and outcomes of health care programs
to allocate health care resources efficiently. Primordial Prevention of CVD including
lifestyle modifications and dietary interventions resulted in substantial financial savings
and is strongly recommended.
Keywords
Fulltext
The full text is available in PDF.
References
-
1.
The references are available in PDF.
Copyright
© 2018, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.